Wang Y, Li N, Guan W, Wang D
FASEB J. 2025; 39(6):e70468.
PMID: 40079203
PMC: 11904867.
DOI: 10.1096/fj.202402775RR.
Saritas Erdogan S, Yilmaz A, Kumbasar A
FEBS Lett. 2024; 598(23):2910-2925.
PMID: 39245791
PMC: 11627009.
DOI: 10.1002/1873-3468.15010.
Garcia-Yague A, Cuadrado A
Int J Mol Sci. 2023; 24(15).
PMID: 37569656
PMC: 10419244.
DOI: 10.3390/ijms241512280.
He F, Chen J, Zhao T, Wu Q, Yin N, Wang X
J Enzyme Inhib Med Chem. 2023; 38(1):2227777.
PMID: 37357764
PMC: 10294756.
DOI: 10.1080/14756366.2023.2227777.
Zhang M, Shi Z, Zhang S, Li X, To S, Peng Y
Cancers (Basel). 2023; 15(1).
PMID: 36612021
PMC: 9817892.
DOI: 10.3390/cancers15010024.
Cytokine exposure mediates transcriptional activation of the orphan nuclear receptor Nur77 in hematopoietic cells.
Di Martino O, Niu H, Hadwiger G, Ferris M, Welch J
J Biol Chem. 2021; 297(5):101240.
PMID: 34571009
PMC: 8528724.
DOI: 10.1016/j.jbc.2021.101240.
Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.
Chuang H, Zhen Y, Tsai Y, Chuang C, Huang M, Hsiao M
Biomedicines. 2021; 9(4).
PMID: 33807199
PMC: 8065645.
DOI: 10.3390/biomedicines9040359.
Pinning Down the Transcription: A Role for Peptidyl-Prolyl Isomerase Pin1 in Gene Expression.
Hu X, Chen L
Front Cell Dev Biol. 2020; 8:179.
PMID: 32266261
PMC: 7100383.
DOI: 10.3389/fcell.2020.00179.
Function of PIN1 in Cancer Development and Its Inhibitors as Cancer Therapeutics.
Yu J, Im C, Min S
Front Cell Dev Biol. 2020; 8:120.
PMID: 32258027
PMC: 7089927.
DOI: 10.3389/fcell.2020.00120.
Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis.
Guan Y, Huang Q, Ai Y, Chen Q, Zhao W, Wang X
Oncogene. 2020; 39(11):2408-2423.
PMID: 31959898
PMC: 7067692.
DOI: 10.1038/s41388-020-1158-y.
Function of Nr4a Orphan Nuclear Receptors in Proliferation, Apoptosis and Fuel Utilization Across Tissues.
Herring J, Elison W, Tessem J
Cells. 2019; 8(11).
PMID: 31683815
PMC: 6912296.
DOI: 10.3390/cells8111373.
Key Functions and Therapeutic Prospects of Nur77 in Inflammation Related Lung Diseases.
Banno A, Lakshmi S, Reddy A, Kim S, Reddy R
Am J Pathol. 2018; 189(3):482-491.
PMID: 30414411
PMC: 6458520.
DOI: 10.1016/j.ajpath.2018.10.002.
The E3 ubiquitin ligase Trim13 regulates Nur77 stability via casein kinase 2α.
Huang B, Pei H, Chang H, Baek S
Sci Rep. 2018; 8(1):13895.
PMID: 30224829
PMC: 6141542.
DOI: 10.1038/s41598-018-32391-5.
Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.
Chen Y, Wu Y, Yang H, Li X, Jie M, Hu C
Cell Death Dis. 2018; 9(9):883.
PMID: 30158600
PMC: 6115400.
DOI: 10.1038/s41419-018-0844-y.
Oxidized analogs of Di(1-indol-3-yl)methyl-4-substituted benzenes are NR4A1-dependent UPR inducers with potent and safe anti-cancer activity.
Sanchez M, Xia Z, Rico-Bautista E, Cao X, Cuddy M, Castro D
Oncotarget. 2018; 9(38):25057-25074.
PMID: 29861853
PMC: 5982742.
DOI: 10.18632/oncotarget.25285.
SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death.
Zhang L, Xie F, Zhang J, Ten Dijke P, Zhou F
Cell Death Differ. 2017; 24(9):1530-1539.
PMID: 28622293
PMC: 5563982.
DOI: 10.1038/cdd.2017.29.
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.
Campaner E, Rustighi A, Zannini A, Cristiani A, Piazza S, Ciani Y
Nat Commun. 2017; 8:15772.
PMID: 28598431
PMC: 5472749.
DOI: 10.1038/ncomms15772.
Grb7 Protein Stability Modulated by Pin1 in Association with Cell Cycle Progression.
Tai Y, Tung L, Lin Y, Lu P, Chu P, Wang M
PLoS One. 2016; 11(9):e0163617.
PMID: 27658202
PMC: 5033455.
DOI: 10.1371/journal.pone.0163617.
The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.
Zhou X, Lu K
Nat Rev Cancer. 2016; 16(7):463-78.
PMID: 27256007
DOI: 10.1038/nrc.2016.49.
The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer.
Beard J, Tenga A, Chen T
Cell Signal. 2014; 27(2):257-66.
PMID: 25446259
PMC: 4276441.
DOI: 10.1016/j.cellsig.2014.11.009.